Learn how to optimise eConsent for maximum patient centricity.
Currently, according to Tufts researchers, clinical trials in a variety of therapeutic areas experience patient dropout rates close to 20%, with the consent process being the number 1 factor contributing to this figure. It is critical that the consent process be tailored to ensure that participants understand what's being asked of them and how their data will help further future disease treatment. The Solution: eConsent Click here to learn how to optimise eConsent for maximum patient centricity. |
|
No comments